M&G PLC has acquired a new position in Abbott Laboratories, purchasing 237,694 shares valued at approximately $31.85 million during the third quarter. This move is part of a broader trend of institutional investors modifying their holdings in Abbott Laboratories, with several firms increasing their stakes. The article also touches on insider activity, the company’s financial performance, recent dividend increase, and updated analyst ratings for ABT.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
M&G PLC Buys New Shares in Abbott Laboratories $ABT
M&G PLC has acquired a new position in Abbott Laboratories, purchasing 237,694 shares valued at approximately $31.85 million during the third quarter. This move is part of a broader trend of institutional investors modifying their holdings in Abbott Laboratories, with several firms increasing their stakes. The article also touches on insider activity, the company’s financial performance, recent dividend increase, and updated analyst ratings for ABT.